Effect of the different glyco-engineering tools on sum of high-mannose and hybrid-type glycosylation traits; A) 2FF addition (N=3), B) GNTIII co-transfection (N=2), C) 2FG addition (N=4), D) B4GALT1 co-transfection (N=2), E) 1% B4GALT1 co-transfection with D-galactose addition (N=2), F) 1% B4GALT1 co-transfection and 5mM D-galactose addition in combination with ST6GALT co-transfection (N=2). The data represents means and SD combined independent experiments, *, **, *** and **** denote a statistical significance of p≤0.05, p≤0.01, p≤0.001 and p≤0.0001, respectively, as tested by one-way ANOVA using Dunnett's multiple comparisons test. The vertical dotted lines in represent the designated optimal concentrations of the indicated vector or substrate. 
Supplemental table 1
Comprehensive list of the IgG1 N-glycans which were detected during data analysis. Glycan structures are described in two ways: based on the number of monosacharide residues of which the glycan is composed (with H = hexose, N = N-acetylhexosamine, F = fucose and S = N-acetylneuraminic acid) and using the alternative nomenclature often used to describe polyclonal IgG N-glycans (with G = galactose, N = bisecting Nacetylglucosamine, F = core fucose and S = N-acetylneuraminic acid). The theoretical m/z value was calculated for each glycopeptide in various charge states. The label 'out of range' was added if the m/z value fell outside of the range of the analysis (m/z 500-1800).
